ESC 365 - The impact of intravenous ferric carboxymaltose on reverse electrical remodeling following cardiac resynchronization therapy

EHRA Premium Access

The impact of intravenous ferric carboxymaltose on reverse electrical remodeling following cardiac resynchronization therapy

Session: ePoster session 26

Topic: Clinical

Speaker: Associate Professor E. Bozcali (Istanbul, TR)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Associate Professor Evin Bozcali

Cemil Tascioglu City Hospital, Istanbul (Türkiye)

0 follower

9 more presentations in this session

Trends in the use of implantable loop recordertrends and diagnostic rate of the implantable loop recorder in nationwide database

Speaker: Doctor S. Roh (Seoul, KR)

QRS progression over time in heart failure patients: a robust marker of disease progression irrespective of aetiology

Very high power- short duration radiofrequency ablation in patients with congenital heart disease and atrial fibrillation: safety and outcome

Speaker: Doctor S. Lengauer (Munich, DE)

Pulsed field ablation for atrial tachycardia following prior persistent atrial fibrillation ablation and resistant to radiofrequency energy

Speaker: Associate Professor M. Fiala (Brno, CZ)

Systematic identification of low voltage-high frequency electrogram zones at sites of left atrial reentrant tachycardia termination

Speaker: Doctor L. Guido Lopez (Madrid, ES)

Access the full session

ePoster session 26

Speakers: Associate Professor E. Bozcali, Doctor S. Roh, Doctor S. Lengauer, Associate Professor M. Fiala, Doctor L. Guido Lopez

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources